Skip to main content
SpringerLink
Log in

Immunobiological and Neural Substrates of Cancer-Related Neurocognitive Deficits

  • Chapter
The Neuroimmunological Basis of Behavior and Mental Disorders

  • 1310 Accesses

Abstract

In addition to neurocognitive deficits, cancer patients may also experience fatigue, mood disorders, sleep disturbance, and sexual dysfunction, all of which are factors that negatively affect both neurocognitive functioning and healthrelated quality of life. The exact mechanisms responsible for neurocognitive and behavioral symptoms in cancer patients are not well understood, challenging clinicians to develop effective treatments.

Side effects related to systemic chemotherapy and radiotherapy have been extensively investigated in clinical trials, but the effect of cancer treatment on neurocognitive function is one of the less well-characterized experiences of the patient. Apart from the ability of chemotherapy to enter the brain across the blood-brain barrier, DNA damage and shortened telomere length resulting from chemotherapy, problems with neural repair such as the presence of apolipoprotein E4 alleles, and decreased neurotransmitter activity as potential mechanisms underlying neurocognitive deficits in cancer patients, problems with cytokine regulation might provide an important explanations of compromised neurocognitive functioning. This chapter will discuss how changes in levels of cytokines are associated with changes in neurocognitive functioning in cancer patients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Ader R, Cohen N, Felten D. Psychoneuroimmunology: interactions between the nervous system and the immune system. Lancet. Jan 14 1995;345(8942):99–103.

    Google Scholar 

  • Aggarwal BB, Shishodia S, Sandur SK, Pandey MK, Sethi G. Inflammation and cancer: how hot is the link? Biochem Pharmacol. Nov 30 2006;72(11):1605–1621.

    Google Scholar 

  • Ahles TA, Saykin AJ. Candidate mechanisms for chemotherapy-induced cognitive changes. Nat Rev Cancer. Mar 2007;7(3):192–201.

    Google Scholar 

  • Aloisi F, Borsellino G, Care A, et al. Cytokine regulation of astrocyte function: in-vitro studies using cells from the human brain. Int J Dev Neurosci. Jun–Jul 1995;13(3–4):265–274.

    Google Scholar 

  • Anisman H, Merali Z. Anhedonic and anxiogenic effects of cytokine exposure. Adv Exp Med Biol. 1999;461:199–233.

    Article  PubMed  CAS  Google Scholar 

  • Anisman H, Merali Z. Cytokines, stress, and depressive illness. Brain Behav Immun. Oct 2002;16(5):513–524.

    Google Scholar 

  • Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet. Feb 17 2001;357(9255):539–545.

    Google Scholar 

  • Barrientos RM, Sprunger DB, Campeau S, Watkins LR, Rudy JW, Maier SF. BDNF mRNA expression in rat hippocampus following contextual learning is blocked by intrahippocampal IL-1beta administration. J Neuroimmunol. Oct 2004;155(1–2):119–126.

    Google Scholar 

  • Beattie EC, Stellwagen D, Morishita W, et al. Control of synaptic strength by glial TNFalpha. Science. Mar 22 2002;295(5563):2282–2285.

    Google Scholar 

  • Bellinger FP, Madamba S, Siggins GR. Interleukin 1 beta inhibits synaptic strength and long-term potentiation in the rat CA1 hippocampus. Brain Res. Nov 19 1993;628(1–2):227–234.

    Google Scholar 

  • Bierhaus A, Wolf J, Andrassy M, et al. A mechanism converting psychosocial stress into mononuclear cell activation. Proc Natl Acad Sci USA. Feb 18 2003;100(4):1920–1925.

    Google Scholar 

  • Bower JE, Ganz PA, Aziz N, Fahey JL. Fatigue and proinflammatory cytokine activity in breast cancer survivors. Psychosom Med. Jul–Aug 2002;64(4):604–611.

    Google Scholar 

  • Brebner K, Hayley S, Zacharko R, Merali Z, Anisman H. Synergistic effects of interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha: central monoamine, corticosterone, and behavioral variations. Neuropsychopharmacology. Jun 2000;22(6):566–580.

    Google Scholar 

  • Breder CD, Dinarello CA, Saper CB. Interleukin-1 immunoreactive innervation of the human hypothalamus. Science. Apr 15 1988;240(4850):321–324.

    Google Scholar 

  • Breder CD, Tsujimoto M, Terano Y, Scott DW, Saper CB. Distribution and characterization of tumor necrosis factor-alpha-like immunoreactivity in the murine central nervous system. J Comp Neurol. Nov 22 1993;337(4):543–567.

    Google Scholar 

  • Camacho A, Ng B. Methylphenidate for alpha-interferon induced depression. J Psychopharmacol (Oxf). Sep 2006;20(5):687–689.

    Google Scholar 

  • Capuron L, Ravaud A, Dantzer R. Timing and specificity of the cognitive changes induced by interleukin-2 and interferon-alpha treatments in cancer patients. Psychosom Med. May–Jun 2001;63(3):376–386.

    Google Scholar 

  • Cleeland CS, Bennett GJ, Dantzer R, et al. Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms. Cancer. Jun 1 2003;97(11):2919–2925.

    Google Scholar 

  • Collado-Hidalgo A, Bower JE, Ganz PA, Cole SW, Irwin MR. Inflammatory biomarkers for persistent fatigue in breast cancer survivors. Clin Cancer Res. May 1 2006;12(9):2759–2766.

    Google Scholar 

  • Coogan A, O’Connor JJ. Inhibition of NMDA receptor-mediated synaptic transmission in the rat dentate gyrus in vitro by IL-1 beta. Neuroreport. Jul 7 1997;8(9–10):2107–2110.

    Google Scholar 

  • Crane JW, Buller KM, Day TA. Evidence that the bed nucleus of the stria terminalis contributes to the modulation of hypophysiotropic corticotropin-releasing factor cell responses to systemic interleukin-1beta. J Comp Neurol. Dec 8 2003;467(2):232–242.

    Google Scholar 

  • Cserr HF, Knopf PM. Cervical lymphatics, the blood-brain barrier and the immunoreactivity of the brain: a new view. Immunol Today. Dec 1992;13(12):507–512.

    Google Scholar 

  • Cunningham AJ, Murray CA, O’Neill LA, Lynch MA, O’Connor JJ. Interleukin-1 beta (IL-1 beta) and tumour necrosis factor (TNF) inhibit long-term potentiation in the rat dentate gyrus in vitro. Neurosci Lett. Jan 12 1996;203(1):17–20.

    Google Scholar 

  • Dantzer R. Cytokine-induced sickness behaviour: a neuroimmune response to activation of innate immunity. Eur J Pharmacol. Oct 1 2004;500(1–3):399–411.

    Google Scholar 

  • D’Arcangelo G, Dodt HU, Zieglgansberger W. Reduction of excitation by interleukin-1 beta in rat neocortical slices visualized using infrared-darkfield videomicroscopy. Neuroreport. May 27 1997;8(8):2079–2083.

    Google Scholar 

  • De Simoni MG, Imeri L. Cytokine-neurotransmitter interactions in the brain. Biol Signals. Jan 1998;7(1):33–44.

    Google Scholar 

  • de Visser KE, Eichten A, Coussens LM. Paradoxical roles of the immune system during cancer development. Nat Rev Cancer. Jan 2006;6(1):24–37.

    Google Scholar 

  • Duman RS, Monteggia LM. A neurotrophic model for stress-related mood disorders. Biol Psychiatry. Jun 15 2006;59(12):1116–1127.

    Google Scholar 

  • Dunn AJ, Wang J, Ando T. Effects of cytokines on cerebral neurotransmission. Comparison with the effects of stress. Adv Exp Med Biol. 1999;461:117–127.

    Article  PubMed  CAS  Google Scholar 

  • Felten SY, Felten DL. Innervation of Lymphoid Tissue. 2nd ed. San Diego, CA: Academic Press; 1991.

    Google Scholar 

  • Flor-Henry P. On certain aspects of the localization of the cerebral systems regulating and determining emotion. Biol Psychiatry. 1979;133(677–698).

    Google Scholar 

  • Frank MG, Baratta MV, Sprunger DB, Watkins LR, Maier SF. Microglia serve as a neuroimmune substrate for stress-induced potentiation of CNS pro-inflammatory cytokine responses. Brain Behav Immun. Jan 2007;21(1):47–59.

    Google Scholar 

  • Freidin M, Bennett MV, Kessler JA. Cultured sympathetic neurons synthesize and release the cytokine interleukin 1 beta. Proc Natl Acad Sci USA. Nov 1 1992;89(21):10440–10443.

    Google Scholar 

  • Gloeckler Ries LA, Reichman ME, Lewis DR, Hankey BF, Edwards BK. Cancer survival and incidence from the Surveillance, Epidemiology, and End Results (SEER) program. Oncologist. 2003;8(6):541–552.

    Article  PubMed  Google Scholar 

  • Harbuz MS, Stephanou A, Sarlis N, Lightman SL. The effects of recombinant human interleukin (IL)-1 alpha, IL-1 beta or IL-6 on hypothalamo-pituitary-adrenal axis activation. J Endocrinol. Jun 1992;133(3):349–355.

    Google Scholar 

  • Hopkins SJ, Rothwell NJ. Cytokines and the nervous system. I: Expression and recognition. Trends Neurosci. Feb 1995;18(2):83–88.

    Google Scholar 

  • Johnson JD, Campisi J, Sharkey CM, et al. Catecholamines mediate stress-induced increases in peripheral and central inflammatory cytokines. Neuroscience. 2005;135(4):1295–1307.

    Article  PubMed  CAS  Google Scholar 

  • Katsuki H, Nakai S, Hirai Y, Akaji K, Kiso Y, Satoh M. Interleukin-1 beta inhibits long-term potentiation in the CA3 region of mouse hippocampal slices. Eur J Pharmacol. Jun 8 1990;181(3):323–326.

    Google Scholar 

  • Kelley KW, Bluthe RM, Dantzer R, et al. Cytokine-induced sickness behavior. Brain Behav Immun. Feb 2003;17 Suppl 1:S112–118.

    Google Scholar 

  • Kendler KS, Karkowski LM, Prescott CA. Causal relationship between stressful life events and the onset of major depression. Am J Psychiatry. Jun 1999;156(6):837–841.

    Google Scholar 

  • Kent S, Bluthe RM, Kelley KW, Dantzer R. Sickness behavior as a new target for drug development. Trends Pharmacol Sci. Jan 1992;13(1):24–28.

    Google Scholar 

  • Kent S, Bret-Dibat JL, Kelley KW, Dantzer R. Mechanisms of sickness-induced decreases in food-motivated behavior. Neurosci Biobehav Rev. 1996;20(1):171–175.

    Article  PubMed  CAS  Google Scholar 

  • Kronfol Z, Remick DG. Cytokines and the brain: implications for clinical psychiatry. Am J Psychiatry. May 2000;157(5):683–694.

    Google Scholar 

  • Kronfol Z, Hamsher K, Digre K, Waziri R. Depression and hemisphere functions: changes associated with unilateral ECT. Br J Psychiatry. 1978;132:560–567.

    Article  PubMed  CAS  Google Scholar 

  • Lacosta S, Merali Z, Anisman H. Central monoamine activity following acute and repeated systemic interleukin-2 administration. Neuroimmunomodulation. 2000;8(2):83–90.

    Article  PubMed  CAS  Google Scholar 

  • Lapchak PA, Araujo DM. Interleukin-2 regulates monoamine and opioid peptide release from the hypothalamus. Neuroreport. Mar 1993;4(3):303–306.

    Google Scholar 

  • Linthorst AC, Flachskamm C, Muller-Preuss P, Holsboer F, Reul JM. Effect of bacterial endotoxin and interleukin-1 beta on hippocampal serotonergic neurotransmission, behavioral activity, and free corticosterone levels: an in vivo microdialysis study. J Neurosci. Apr 1995;15(4):2920–2934.

    Google Scholar 

  • Linthorst AC, Reul JM. Brain neurotransmission during peripheral inflammation. Ann NY Acad Sci. May 1 1998;840:139–152.

    Google Scholar 

  • Maes M, Meltzer HY, Bosmans E, et al. Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression. J Affect Disord. Aug 18 1995;34(4):301–309.

    Google Scholar 

  • Maier SF, Watkins LR. Intracerebroventricular interleukin-1 receptor antagonist blocks the enhancement of fear conditioning and interference with escape produced by inescapable shock. Brain Res. Oct 16 1995;695(2):279–282.

    Google Scholar 

  • Maier SF, Watkins LR. Cytokines for psychologists: implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition. Psychol Rev. Jan 1998;105(1):83–107.

    Google Scholar 

  • McGeer PL, McGeer EG. The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res Brain Res Rev. Sep 1995;21(2):195–218.

    Google Scholar 

  • Merali Z, Lacosta S, Anisman H. Effects of interleukin-1beta and mild stress on alterations of norepinephrine, dopamine and serotonin neurotransmission: a regional microdialysis study. Brain Res. Jul 4 1997;761(2):225–235.

    Google Scholar 

  • Meyers CA, Albitar M, Estey E. Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome. Cancer. Aug 15 2005;104(4):788–793.

    Google Scholar 

  • Milligan ED, Nguyen KT, Deak T, et al. The long term acute phase-like responses that follow acute stressor exposure are blocked by alpha-melanocyte stimulating hormone. Brain Res Bull. Nov 9 1998;810(1–2):48–58.

    Google Scholar 

  • Montkowski A, Landgraf R, Yassouridis A, Holsboer F, Schobitz B. Central administration of IL-1 reduces anxiety and induces sickness behaviour in rats. Pharmacol Biochem Behav. Oct 1997;58(2):329–336.

    Google Scholar 

  • Muller N, Ackenheil M. Psychoneuroimmunology and the cytokine action in the CNS: implications for psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry. Jan 1998;22(1):1–33.

    Google Scholar 

  • Munoz-Fernandez MA, Fresno M. The role of tumour necrosis factor, interleukin 6, interferon-gamma and inducible nitric oxide synthase in the development and pathology of the nervous system. Prog Neurobiol. Oct 1998;56(3):307–340.

    Google Scholar 

  • Nguyen KT, Deak T, Will MJ, et al. Timecourse and corticosterone sensitivity of the brain, pituitary, and serum interleukin-1beta protein response to acute stress. Brain Res. Mar 24 2000;859(2):193–201.

    Google Scholar 

  • Ofek K, Krabbe KS, Evron T, et al. Cholinergic status modulations in human volunteers under acute inflammation. J Mol Med. 2007;85(11):1239–1251.

    Article  PubMed  CAS  Google Scholar 

  • Opp MR, Krueger JM. Interleukin 1-receptor antagonist blocks interleukin 1-induced sleep and fever. Am J Physiol. Feb 1991;260(2 Pt 2):R453–457.

    Google Scholar 

  • Pace TW, Mletzko TC, Alagbe O, et al. Increased stress-induced inflammatory responses in male patients with major depression and increased early life stress. Am J Psychiatry. Sep 2006;163(9):1630–1633.

    Google Scholar 

  • Pauli S, Linthorst AC, Reul JM. Tumour necrosis factor-alpha and interleukin-2 differentially affect hippocampal serotonergic neurotransmission, behavioural activity, body temperature and hypothalamic-pituitary-adrenocortical axis activity in the rat. Eur J Neurosci. Mar 1998;10(3):868–878.

    Google Scholar 

  • Pavlov VA, Tracey KJ. The cholinergic anti-inflammatory pathway. Brain Behav Immun. Nov 2005;19(6):493–499.

    Google Scholar 

  • Penson RT, Kronish K, Duan Z, et al. Cytokines IL-1beta, IL-2, IL-6, IL-8, MCP-1, GM-CSF and TNFalpha in patients with epithelial ovarian cancer and their relationship to treatment with paclitaxel. Int J Gynecol Cancer. Jan 2000;10(1):33–41.

    Google Scholar 

  • Plata-Salaman CR, Ffrench-Mullen JM. Interleukin-1 beta depresses calcium currents in CA1 hippocampal neurons at pathophysiological concentrations. Brain Res Bull. Aug 1992;29(2):221–223.

    Google Scholar 

  • Plata-Salaman CR, Ilyin SE, Turrin NP, et al. Neither acute nor chronic exposure to a naturalistic (predator) stressor influences the interleukin-1beta system, tumor necrosis factor-alpha, transforming growth factor-beta1, and neuropeptide mRNAs in specific brain regions. Brain Res Bull. Jan 15 2000;51(2):187–193.

    Google Scholar 

  • Pusztai L, Mendoza TR, Reuben JM, et al. Changes in plasma levels of inflammatory cytokines in response to paclitaxel chemotherapy. Cytokine. Feb 7 2004;25(3):94–102.

    Google Scholar 

  • Rothwell NJ, Hopkins SJ. Cytokines and the nervous system II: Actions and mechanisms of action. Trends Neurosci. Mar 1995;18(3):130–136.

    Google Scholar 

  • Sapolsky RM, Meaney MJ, McEwen BS. The development of the glucocorticoid receptor system in the rat limbic brain. III. Negative-feedback regulation. Brain Res. Feb 1985;350(1–2):169–173.

    Google Scholar 

  • Sapolsky R, Rivier C, Yamamoto G, Plotsky P, Vale W. Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor. Science. Oct 23 1987;238(4826):522–524.

    Google Scholar 

  • Scarborough DE, Lee SL, Dinarello CA, Reichlin S. Interleukin-1 beta stimulates somatostatin biosynthesis in primary cultures of fetal rat brain. Endocrinology. Jan 1989;124(1):549–551.

    Google Scholar 

  • Scheibel RS, Valentine AD, O’Brien S, Meyers CA. Cognitive dysfunction and depression during treatment with interferon-alpha and chemotherapy. J Neuropsychiatry Clin Neurosci. Spring 2004;16(2):185–191.

    CAS  Google Scholar 

  • Schobitz B, De Kloet ER, Holsboer F. Gene expression and function of interleukin 1, interleukin 6 and tumor necrosis factor in the brain. Prog Neurobiol. Nov 1994;44(4):397–432.

    Google Scholar 

  • Schwienbacher I, Fendt M, Richardson R, Schnitzler HU. Temporary inactivation of the nucleus accumbens disrupts acquisition and expression of fear-potentiated startle in rats. Brain Res. 2004;1027(1–2):87–93.

    Article  PubMed  CAS  Google Scholar 

  • Shintani F, Nakaki T, Kanba S, et al. Involvement of interleukin-1 in immobilization stress-induced increase in plasma adrenocorticotropic hormone and in release of hypothalamic monoamines in the rat. J Neurosci. Mar 1995;15(3 Pt 1):1961–1970.

    Google Scholar 

  • Short KR, Maier SF. Stressor controllability, social interaction, and benzodiazepine systems. Pharmacol Biochem Behav. Aug 1993;45(4):827–835.

    Google Scholar 

  • Sikora K, Timbs O. Cancer 2025: introduction. Expert Rev Anticancer Ther. Jun 2004;4 Suppl 1:S11–12.

    Google Scholar 

  • Song C, Merali Z, Anisman H. Variations of nucleus accumbens dopamine and serotonin following systemic interleukin-1, interleukin-2 or interleukin-6 treatment. Neuroscience. 1999;88(3):823–836.

    Article  PubMed  CAS  Google Scholar 

  • Spranger M, Lindholm D, Bandtlow C, et al. Regulation of Nerve Growth Factor (NGF) Synthesis in the Rat Central Nervous System: Comparison between the Effects of Interleukin-1 and Various Growth Factors in Astrocyte Cultures and in vivo. Eur J Neurosci. Jan 1990;2(1):69–76.

    Google Scholar 

  • Sullivan GM, Canfield SM, Lederman S, Xiao E, Ferin M, Wardlaw SL. Intracerebroventricular injection of interleukin-1 suppresses peripheral lymphocyte function in the primate. Neuroimmunomodulation. Jan–Feb 1997;4(1):12–18.

    Google Scholar 

  • Tsavaris N, Kosmas C, Vadiaka M, Kanelopoulos P, Boulamatsis D. Immune changes in patients with advanced breast cancer undergoing chemotherapy with taxanes. Br J Cancer. Jul 1 2002;87(1):21–27.

    Google Scholar 

  • Tonelli LH, Postolache TT, Sternberg EM. Inflammatory genes and neural activity: involvement of immune genes in synaptic function and behavior. Front Biosci. Jan 1 2005;10:675–680.

    Google Scholar 

  • Trask PC, Esper P, Riba M, Redman B. Psychiatric side effects of interferon therapy: prevalence, proposed mechanisms, and future directions. J Clin Oncol. Jun 2000;18(11):2316–2326.

    Google Scholar 

  • Wang TH, Chan YH, Chen CW, et al. Paclitaxel (Taxol) upregulates expression of functional interleukin-6 in human ovarian cancer cells through multiple signaling pathways. Oncogene. 2006;25(35):4857–4866.

    Article  PubMed  CAS  Google Scholar 

  • Wang S, Cheng Q, Malik S, Yang J. Interleukin-1beta inhibits gamma-aminobutyric acid type A (GABA(A)) receptor current in cultured hippocampal neurons. J Pharmacol Exp Ther. Feb 2000;292(2):497–504.

    Google Scholar 

  • Watkins LR, Wiertelak EP, Goehler LE, Smith KP, Martin D, Maier SF. Characterization of cytokine-induced hyperalgesia. Brain Res. Aug 15 1994;654(1):15–26.

    Google Scholar 

  • Wilson CJ, Finch CE, Cohen HJ. Cytokines and cognition – the case for a head-to-toe inflammatory paradigm. J Am Geriatr Soc. Dec 2002;50(12):2041–2056.

    Google Scholar 

  • Xu Y, Day TA, Buller KM. The central amygdala modulates hypothalamic-pituitary-adrenal axis responses to systemic interleukin-1beta administration. Neuroscience. 1999;94(1):175–183.

    Article  PubMed  CAS  Google Scholar 

  • Zeise ML, Espinoza J, Morales P, Nalli A. Interleukin-1beta does not increase synaptic inhibition in hippocampal CA3 pyramidal and dentate gyrus granule cells of the rat in vitro. Brain Res. Sep 12 1997;768(1–2):341–344.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medical Psychology – D349, VU University Medical Center, Van der Boechorststraat 7, 1081 BT Amsterdam, The Netherlands

    Martin Klein

Authors
  1. Martin Klein
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Departments of Neurology and Neuroscience and Psychiatry, University of Medicine and Dentistry of New Jersey — NJ Medical School, Newark, NJ 07103, USA

    Allan Siegel

  2. University of Medicine and Dentistry of New Jersey — NJ Medical School, Newark, NJ 07103, USA

    Steven S. Zalcman

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Klein, M. (2009). Immunobiological and Neural Substrates of Cancer-Related Neurocognitive Deficits. In: Siegel, A., Zalcman, S.S. (eds) The Neuroimmunological Basis of Behavior and Mental Disorders. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-84851-8_16

Download citation

Publish with us

Policies and ethics

Search

Navigation